Cochrane Abstracts
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiangiogenic Therapy With Interferon Alfa for Neovascular Age‐related Macular Degeneration." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431591/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration. Accessed 26 September 2023.
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431591/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration. Accessed September 26, 2023.
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431591/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration
Antiangiogenic Therapy With Interferon Alfa for Neovascular Age‐related Macular Degeneration [Internet]. In: Cochrane Abstracts. [cited 2023 September 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431591/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
ID - 431591
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431591/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration
DB - Evidence Central
DP - Unbound Medicine
ER -
